Thymidine phosphorylase (platelet-derived endothelial cell growth factor), microvessel density and clinical outcome in hepatocellular carcinoma
- 1 August 1998
- journal article
- Published by Elsevier in Journal of Hepatology
- Vol. 29 (2), 290-299
- https://doi.org/10.1016/s0168-8278(98)80015-9
Abstract
No abstract availableKeywords
This publication has 38 references indexed in Scilit:
- The activity and expression of thymidine phosphorylase in human solid tumoursEuropean Journal Of Cancer, 1996
- CD34 expression in endothelial cells of small hepatocellular carcinoma: Its correlation with tumour progression and angiographic findingsJournal of Gastroenterology and Hepatology, 1995
- The correlation of thymidine phosphorylase activity with the expression of interleukin 1α, interferon α and interferon γ in human colorectal carcinomaCancer Letters, 1995
- The expression of thymidine phosphorylase and thrombomodulin in human colorectal carcinomasCancer Letters, 1995
- Expression of platelet‐derived endothelial cell growth factor/thymidine phosphorylase in human breast cancerInternational Journal of Cancer, 1995
- Blood Supply of Early Hepatocellular CarcinomaSeminars in Liver Disease, 1995
- Angiostatin: A novel angiogenesis inhibitor that mediates the suppression of metastases by a lewis lung carcinomaCell, 1994
- Novel growth regulatory factors and tumour angiogenesisEuropean Journal of Cancer and Clinical Oncology, 1991
- Treatment of childhood angiomatous diseases with recombinant interferon alfa-2aThe Journal of Pediatrics, 1991
- What Is the Evidence That Tumors Are Angiogenesis Dependent?JNCI Journal of the National Cancer Institute, 1990